Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Continuous glucose monitoring (CGM) has provided new measures of glycemic control that link to diabetes complications. This study investigated the association between the time in range (TIR) assessed by CGM and diabetic retinopathy (DR). RESEARCH DESIGN AND METHODS: A total of 3,262 patients with type 2 diabetes were recruited. TIR was defined as the percentage of time spent within the glucose range of 3.9–10.0 mmol/L during a 24-h period. Measures of glycemic variability (GV) were assessed as well. DR was determined by using fundus photography and graded as 1) non-DR; 2) mild nonproliferative DR (NPDR); 3) moderate NPDR; or 4) vision-threatening DR (VTDR). RESULTS: The overall prevalence of DR was 23.9% (mild NPDR 10.9%, moderate NPDR 6.1%, VTDR 6.9%). Patients with more advanced DR had significantly less TIR and higher measures of GV (all P for trend <0.01). The prevalence of DR on the basis of severity decreased with ascending TIR quartiles (all P for trend <0.001), and the severity of DR was inversely correlated with TIR quartiles (r = −0.147; P < 0.001). Multinomial logistic regression revealed significant associations between TIR and all stages of DR (mild NPDR, P = 0.018; moderate NPDR, P = 0.014; VTDR, P = 0.019) after controlling for age, sex, BMI, diabetes duration, blood pressure, lipid profile, and HbA1c. Further adjustment of GV metrics partially attenuated these associations, although the link between TIR and the presence of any DR remained significant. CONCLUSIONS: TIR assessed by CGM is associated with DR in type 2 diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Time in range is associated with the risk of microvascular complications and can be used for assessment of glycemic management (57).”
In the citing paper
“These results align with existing literature that emphasizes the clinical benefits of higher TIR, including reduced complications and improved overall health outcomes for individuals with diabetes19,22–24.”
From Impact of digital health interventions on glycemic control and weight management. (2025) · cites this paper as [22]
In the citing paper
“Most recently, the beneficial effects of new medications, such as sodium glucose cotransporter-2 (SGLT-2) agents have helped individuals with type 1 diabetes increase TIR (49-51).”
From Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range (2019) · cites this paper as [49]
In the citing paper
“TIR has been found to be strongly associated with the development or progression of diabetic retinopathy and microalbuminuria in type 1 and type 2 DM.16 17”
From Glucose time in range and peripheral neuropathy in type 2 diabetes mellitus and chronic kidney disease (2020) · cites this paper as [17]
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Global prevalence and major risk factors of diabetic retinopathy
Yau, J. W. Y., Rogers, S. L., Kawasaki, R., Lamoureux, E. L., Kowalski, J. W., Bek, T., Chen, S.-J., Dekker, J. M., Fletcher, A., Grauslund, J., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1909 · Cited by 4,985
Wilkinson, C. P., Ferris, F. L., Klein, R. E., Lee, P. P., Agardh, C. D., Davis, M., Dills, D., Kampik, A., Pararajasegaram, R., & Verdaguer, J. T. (2003) · Ophthalmology · doi:10.1016/s0161-6420(03)00475-5 · Cited by 3,743
Monnier, L., Mas, E., Ginet, C., Michel, F., Villon, L., Cristol, J.-P., & Colette, C. (2006) · JAMA · doi:10.1001/jama.295.14.1681 · Cited by 2,444
International consensus on use of continuous glucose monitoring
Danne, T., Nimri, R., Battelino, T., Bergenstal, R. M., Close, K. L., DeVries, J. H., Garg, S., Heinemann, L., Hirsch, I., Amiel, S. A., et al. (2017) · Diabetes Care · doi:10.2337/dc17-1600 · Cited by 2,069 · cited 2×
“However, HbA1c is unreliable in patients with anemia, hemoglobinopathies, or iron deficiency, and in patients who are pregnant (7).”
BackgroundSelf-citationContinuous glucose monitoring and intensive treatment of type 1 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559
Ceriello, A., Esposito, K., Piconi, L., Ihnat, M. A., Thorpe, J. E., Testa, R., Boemi, M., & Giugliano, D. (2008) · Diabetes · doi:10.2337/db08-0063 · Cited by 1,310
The Diabetes Control and Complications Trial Research Group (1995) · Diabetes · doi:10.2337/diab.44.8.968 · Cited by 1,301
Bolinder, J., Antuna, R., Geelhoed-Duijvestijn, P., Kröger, J., & Weitgasser, R. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31535-5 · Cited by 893
Cited by
Items 101–200 of 568
Current concepts and clinical importance of glycemic variability
Ravi, R., Balasubramaniam, V., Kuppusamy, G., & Ponnusankar, S. (2021) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2021.03.004 · Cited by 38
Protein glycation in diabetes mellitus
Shin, A., Connolly, S. M., & Kabytaev, K. (2023) · Advances in clinical chemistry · doi:10.1016/bs.acc.2022.11.003 · Cited by 38
Mameli, C., Invernizzi, A., Bolchini, A., Bedogni, G., Giani, E., Macedoni, M., Zuccotti, G., Preziosa, C., & Pellegrini, M. (2019) · Journal of Diabetes Research · doi:10.1155/2019/5410672 · Cited by 38
Time in Tight Range for Patients With Type 1 Diabetes: The Time Is Now, or Is It Too Soon?
Hamidi, V., & Pettus, J. (2024) · Diabetes Care · doi:10.2337/dci23-0092 · Cited by 38
Kalra, S., Shaikh, S. S., Priya, G., Baruah, M., Verma, A., Das, A. K., Shah, M., Das, S., Khandelwal, D., Sanyal, D., et al. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00973-0 · Cited by 37
Lu, J., Home, P. D., & Zhou, J. (2020) · Diabetes Care · doi:10.2337/dc20-0561 · Cited by 37
Self-citationThe Association of Time in Range and Diabetic Complications: The Evidence Is Strong
Beck, R. W. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0141 · Cited by 37
Zang, L., Li, Y., Hao, H., Liu, J., Zhang, Q., Gao, F., Wang, H., Chen, Y., Gu, W., Du, J., et al. (2023) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szad060 · Cited by 37
Battelino, T., Lalic, N. M., Hussain, S., Ceriello, A., Majanović, S. K., Davies, S., Topsever, P., Heverly, J., Ulivi, F., Brady, K., et al. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112111 · Cited by 36
Pan, J., Xu, Y., Chen, S., Tu, Y., Mo, Y., Gao, F., Zhou, J., Hu, C., & Jia, W. (2021) · Journal of Diabetes Research · doi:10.1155/2021/6303063 · Cited by 36
Self-citationSheng, X., Xiong, G., Yu, P., & Liu, J.-P. (2020) · International Journal of Endocrinology · doi:10.1155/2020/8879085 · Cited by 35
Varghese, J. S., Ho, J. C., Anjana, R. M., Pradeepa, R., Patel, S. A., Jebarani, S., Baskar, V., Narayan, K. M. V., & Mohan, V. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0672 · Cited by 36
Clinical Application of Time in Range and Other Metrics
Aleppo, G. (2021) · Diabetes Spectrum · doi:10.2337/ds20-0093 · Cited by 35
Lu, J., Wang, C., Cai, J., Shen, Y., Chen, L., Zhang, L., Lu, W., Zhu, W., Hu, G., Xia, T., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab532 · Cited by 35
Self-citationCai, J., Yang, Q., Lu, J., Shen, Y., Wang, C., Chen, L., Zhang, L., Lu, W., Zhu, W., Xia, T., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac692 · Cited by 35
Self-citationAmin, M., Kerr, D. C., Atiase, Y., Aldwikat, R. K., & Driscoll, A. L. (2023) · Sports · doi:10.3390/sports11050101 · Cited by 35
Glennie, J. L., Berard, L., & Levrat‐Guillen, F. (2022) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s346736 · Cited by 34
Silva, R. R. E., Gauza, M. D. M., Guisso, M. E. S., da Silva, J. O. N., & Kohara, S. K. (2023) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000614 · Cited by 33
Carlson, A. L., Criego, A. B., Martens, T. W., & Bergenstal, R. M. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.10.010 · Cited by 33
Danne, T., Schweitzer, M. A., Keuthage, W., Kipper, S., Kretzschmar, Y., Simon, J., Wiedenmann, T., & Ziegler, R. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0360 · Cited by 33
Association of time in range with hemoglobin A1c, glycated albumin and 1,5‐anhydro‐ d ‐glucitol
Ohigashi, M., Osugi, K., Kusunoki, Y., Washio, K., Matsutani, S., Tsunoda, T., Matsuo, T., Konishi, K., Katsuno, T., Namba, M., et al. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13437 · Cited by 33
Xie, P., Deng, B., Zhang, X., Li, Y., Du, C., Rui, S., Deng, W., Boey, J., Armstrong, D. G., Ma, Y., et al. (2021) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3498 · Cited by 33
Wang, Y., Lu, J., Ni, J., Wang, M., Shen, Y., Lu, W., Zhu, W., Bao, Y., Rodbard, D., Vigersky, R. A., et al. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15068 · Cited by 33
Self-citationHeterogeneity of glycaemic phenotypes in type 1 diabetes
Fagherazzi, G., Aguayo, G., Zhang, L., Hanaire, H. P., Picard, S., Sablone, L., Vergès, B. L., Hamamouche, N., Detournay, B., Joubert, M., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06179-4 · Cited by 33
Self-citationCutruzzolà, A., Irace, C., Parise, M., Fiorentino, R., Tripodi, P. F. P., Ungaro, S., Babinsky, V. N., & Gnasso, A. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.06.009 · Cited by 32
LEVIN, P. A., Hoogwerf, B. J., Snell‐Bergeon, J. K., Vigers, T., Pyle, L. L., & Bromberger, L. A. (2020) · Endocrine Practice · doi:10.1016/j.eprac.2020.10.004 · Cited by 32
Kim, M. Y., Kim, G., Park, J. Y., Choi, M. S., Jun, J. E., Lee, Y.-B., Jin, S.-M., Hur, K. Y., & Kim, J. H. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0599 · Cited by 30
Zhang, J., Yang, J., Liu, L., Li, L., Cui, J., Wu, S., & Tang, K. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00753-2 · Cited by 32
Lee, S., Jeevaratnam, K., Liu, T., Chang, D., Chang, C., Wong, W. T., Wong, I. C. K., Lip, G. Y. H., & Tse, G. (2021) · Clinical Cardiology · doi:10.1002/clc.23728 · Cited by 32
Samson, S. L., Vellanki, P., Blonde, L., Hirsch, I. B., Hoang, T. D., Isaacs, S. D., Izuora, K. E., Wang, C. C. L., Ooi, C. P., Padilla, B. I., et al. (2026) · Endocrine Practice · doi:10.1016/j.eprac.2026.01.006 · Cited by 33
Sanz-Gonzalez, S. M., García‐Medina, J. J., Zanón‐Moreno, V., Gálvez, M. I. L., Galarreta, D., Duarte, L., Valero-Velló, M., Ramirez, A. I., Arévalo, J. F., Pinazo-Duran, M. D., et al. (2020) · Antioxidants · doi:10.3390/antiox9111101 · Cited by 31
A new detection model of microaneurysms based on improved FC-DenseNet
Wang, Z., Li, X., Yao, M., Li, J., Jiang, Q., & Yan, B. (2022) · Scientific Reports · doi:10.1038/s41598-021-04750-2 · Cited by 31
Zhao, X., Zhang, W., Xin, S., Yu, X., & Zhang, X. (2022) · Sleep And Breathing · doi:10.1007/s11325-021-02556-0 · Cited by 31
Mohan, V., Joshi, S., Mithal, A., Kesavadev, J., Unnikrishnan, A., Saboo, B., Kumar, P. R. G., Chawla, M. S., Bhograj, A., & KOVIL, R. R. (2023) · Diabetes Therapy · doi:10.1007/s13300-022-01355-4 · Cited by 31
Wang, Y., Lu, J., Yu, J., Ni, J., Wang, M., Lu, W., Zhu, W. M., Guo, J., Bao, Y., & Zhou, J. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16143 · Cited by 30
Self-citationIncreased Hemoglobin A1c Time in Range Reduces Adverse Health Outcomes in Older Adults With Diabetes
Prentice, J. C., Mohr, D. C., Zhang, L., Li, D., Legler, A., Nelson, R. E., & Conlin, P. R. (2021) · Diabetes Care · doi:10.2337/dc21-0292 · Cited by 30
Self-citationMesa, A., Giménez, M., Pueyo, I., Perea, V., Viñals, C., Blanco, J., Vinagre, I., Serés‐Noriega, T., Boswell, L., Esmatjes, E., et al. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109938 · Cited by 30
Cai, J., Liu, J., Lu, J., Ni, J., Wang, C., Chen, L., Lu, W., Zhu, W., Xia, T., & Zhou, J. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16212 · Cited by 29
Self-citationPérez-López, P., Fernández-Velasco, P., Bahillo-Curieses, P., de Luis, D. A., & Díaz-Soto, G. (2023) · Endocrine · doi:10.1007/s12020-023-03511-7 · Cited by 29
Reid, L. J., Gibb, F. W., Colhoun, H. M., Wild, S. H., Strachan, M. W. J., Madill, K., Dhillon, B., & Forbes, S. (2021) · Diabetologia · doi:10.1007/s00125-021-05456-w · Cited by 29
Zavitsanou, S., MASSA, J. S., Deshpande, S., Pinsker, J. E., Church, M. M., ANDRE, C. C., Doyle, F. J., Michelson, A., Creason, J., Dassau, E., et al. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0109 · Cited by 28
Critical Reappraisal of the Time-in-Range: Alternative or Useful Addition to Glycated Hemoglobin?
Heinemann, L., Freckmann, G., Müller‐Wieland, D., & Kellerer, M. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819883885 · Cited by 28
Szmuilowicz, E. D., & Aleppo, G. (2022) · Postgraduate Medicine · doi:10.1080/00325481.2022.2110507 · Cited by 27
Aktürk, H. K., Battelino, T., Castañeda, J., Arrieta, A., van den Heuvel, T. R. A., & Cohen, O. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0432 · Cited by 27
Urakami, T., Yoshida, K., Kuwabara, R., Mine, Y., Aoki, M., Suzuki, J., & Morioka, I. (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13618 · Cited by 26
Time in range—A new gold standard in type 2 diabetes research?
Goshrani, A., Lin, R., O'Neal, D. N., & Ekinci, E. I. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16279 · Cited by 26
Vascular Inflammation Risk Factors in Retinal Disease
Soto, I., Krebs, M. P., Reagan, A. M., & Howell, G. R. (2019) · Annual Review of Vision Science · doi:10.1146/annurev-vision-091517-034416 · Cited by 26
Yang, Y., Zhao, L., Li, D., Xu, F., Wang, X., Lu, C., Wang, C., Yu, C., Zhang, X., Ning, L.-Y., et al. (2021) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-021-00720-w · Cited by 26
Smith, K., Taylor, G., Brunsgaard, L. H., Walker, M., Davies, K. A. B., Stevenson, E., & West, D. J. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2022-002820 · Cited by 26
Bezerra, M. F., Neves, C., Neves, J. S., & Carvalho, D. M. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01219-2 · Cited by 26
Guo, Q., Lu, B., Guo, Z., Feng, Z., Yuan, Y., Jin, X., Zang, P., Gu, P., & Shao, J. (2020) · World Journal of Diabetes · doi:10.4239/wjd.v11.i11.489 · Cited by 26
Kim, Y.-I., Choi, Y., & Park, J. (2023) · Physical Activity and Nutrition · doi:10.20463/pan.2023.0028 · Cited by 25
Tecce, N., Cennamo, G., Rinaldi, M., Costagliola, C., & Colao, A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13030831 · Cited by 25
Mellor, J., Jeyam, A., Beulens, J. W. J., Bhandari, S., Broadhead, G., Chew, E. Y., Fickweiler, W., van der Heijden, A. A. W. A., Gordin, D., Simó, R., et al. (2024) · Ophthalmology Science · doi:10.1016/j.xops.2024.100494 · Cited by 25
Use of Diabetes Technologies and Retinopathy in Adults With Type 1 Diabetes
Liu, T. Y. A., Shpigel, J., Khan, F., Smith, K. E., Prichett, L. M., Channa, R., Kanbour, S., Jones, M., Abusamaan, M. S., Sidhaye, A. R., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.0728 · Cited by 25
Peng, J., Lu, J., Ma, X., Ying, L., Lu, W., Zhu, W., Bao, Y., & Zhou, J. (2018) · British Journal Of Nutrition · doi:10.1017/s0007114518003628 · Cited by 25
Self-citationChung, S. M., Lee, Y. H., Kim, C. O., Lee, J. Y., Jin, S., Yoo, S.-H., Moon, J. S., & Kim, K. J. (2021) · Journal of Korean Medical Science · doi:10.3346/jkms.2021.36.e190 · Cited by 24
Wang, Y., Lu, J., Shen, Y., Ni, J., Zhang, L., Lu, W., Zhu, W., Bao, Y., & Zhou, J. (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13811 · Cited by 24
Self-citationZhai, L., Lü, J., Cao, X., Zhang, J., Yin, Y., & Hu, T. (2022) · Hormone and Metabolic Research · doi:10.1055/a-1931-4400 · Cited by 24
Chinese clinical guidelines for continuous glucose monitoring (2018 edition)
Bao, Y., Chen, L., Chen, L., Dou, J., Gao, Z., Gao, L., Guo, L., Guo, X., Ji, L., Ji, Q., et al. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3152 · Cited by 24
Self-citationvan Raalte, D. H., & Bjornstad, P. (2019) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfz228 · Cited by 24
Thomsen, M. N., Skytte, M. J., Astrup, A. V., Deacon, C. F., Holst, J. J., Madsbad, S., Krarup, T., Haugaard, S. B., & Samkani, A. (2020) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2020.07.002 · Cited by 24
Gao, F., Ma, X., Peng, J., Lu, J., Lu, W., Zhu, W., Bao, Y., Vigersky, R. A., Jia, W., & Zhou, J. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0290 · Cited by 24
Self-citationAnticoagulation protocol and early prosthetic valve thrombosis.
Talwar, S., Kapoor, C. K., Devagourou, V., & Kumar, A. S. (2004) · PubMed · Cited by 24
Vianna, A. G. D., de Lacerda, C. S., Pechmann, L. M., Polesel, M. G., Marino, E. C., Scharf, M., Detsch, J. M., Marques, K., & Sanches, C. P. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13913 · Cited by 23
Time in Range as a Research Outcome Measure
Timmons, J. G., Boyle, J. G., & Petrie, J. R. (2021) · Diabetes Spectrum · doi:10.2337/ds20-0097 · Cited by 23
Current landscape and comprehensive management of glycemic variability in diabetic retinopathy
Chen, B., Shen, C., & Sun, B. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05516-w · Cited by 23
Firouzabadi, F. D., Poopak, A., Samimi, S., Deravi, N., Nakhaei, P., Sheikhy, A., Moosaie, F., Rabizadeh, S., Meysamie, A., Nakhjavani, M., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1383345 · Cited by 23
Li, J., Li, Y., Ma, W., Liu, Y., Yin, X., Xie, C., Bai, J., & Zhang, M. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.09.028 · Cited by 23
Beck, R. W., & Bergenstal, R. M. (2021) · Diabetes Spectrum · doi:10.2337/ds20-0090 · Cited by 23
Anagnostopoulou, L., Liarakos, A. L., Ntanasis‐Stathopoulos, I., Briasoulis, Α., & Tentolouris, A. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70288 · Cited by 22
Using continuous glucose monitoring data in daily clinical practice
Martens, T. W., Simonson, G. D., & Bergenstal, R. M. (2024) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.91a.23090 · Cited by 22
Kim, G., Lim, S. K., Kwon, H., Park, I. B., Ahn, K. J., Park, C., Kwon, S. K., Kim, H. S., Park, S. W., Kim, S. G., et al. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14061 · Cited by 22
Continuous glucose monitoring in primary care – are we there?
Martens, T. W. (2021) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000689 · Cited by 21
Association of time in range with postoperative wound healing in patients with diabetic foot ulcers
Huang, Z., Zhang, H., Huang, Y., Ye, S.-L., Ma, Y., Xin, Y., Chen, X., & Zhao, S. (2021) · International Wound Journal · doi:10.1111/iwj.13725 · Cited by 21
Eliasson, B., Kjölhede, E. A., Salö, S., Nielsen, N. F., & Eeg‐Olofsson, K. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01572-z · Cited by 21
Ying, L. P., Yin, O. X., Quan, O. W., Jain, N., Mayuren, J., Pandey, M., Gorain, B., & Candasamy, M. (2024) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-024-01349-x · Cited by 23
Self-citationWysocka‐Mincewicz, M., Baszyńska–Wilk, M., Gołębiewska, J., Olechowski, A., Byczyńska, A., Hautz, W., & Szalecki, M. (2020) · Journal of Diabetes Research · doi:10.1155/2020/4742952 · Cited by 21
Niu, Y., Zhang, W., Shi, J., Liu, Y., Zhang, H., Lin, N., Li, X., Qin, L., YANG, Z. K., & Su, Q. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.627395 · Cited by 21
Ling, J., Ng, J. K., Lau, E. S. H., Ronald, C. W., Kong, A. P. S., Luk, A. O. Y., Kwok, J. S.-S., Szeto, C., Chan, J. C. N., & Chow, E. (2022) · Kidney International Reports · doi:10.1016/j.ekir.2022.03.029 · Cited by 20
Li, C., Ma, X., Lu, J., Tao, R., Yu, X., Mo, Y., Lu, W., Bao, Y., Zhou, J., & Jia, W. (2022) · Frontiers of Medicine · doi:10.1007/s11684-022-0955-9 · Cited by 20
Self-citationTakao, T., Suka, M., Yanagisawa, H., & Kasuga, M. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13403 · Cited by 19
Al-Harbi, M. Y., Albunyan, A., Nahari, A., Kao, K., Brandner, L., Jammal, M. E., & Dunn, T. C. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00831-y · Cited by 19
Paing, A. C., McMillan, K. A., Kirk, A. F., Collier, A., Hewitt, A., & CHASTIN, S. F. M. (2019) · European Journal of Applied Physiology · doi:10.1007/s00421-019-04261-z · Cited by 19
The dawn phenomenon across the glycemic continuum: Implications for defining dysglycemia
Li, C., Ma, X., Yin, J., Mo, Y., Zhang, L., Lu, J., Lu, W., Bao, Y., Vigersky, R. A., Zhou, J., et al. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108308 · Cited by 19
Self-citationChan, N. B., Li, W., Aung, T., Bazuaye, E., & Montero, R. (2023) · JMIR AI · doi:10.2196/45450 · Cited by 18
Liang, Y., Liang, J., Jiang, W., Wang, W., Yang, X., Liu, Y., Jin, X., Guo, Q., Xu, Y., Lü, B., et al. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01515-5 · Cited by 18
Gavin, J. R., & Bailey, C. J. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0057 · Cited by 18
Ruan, Y., Zhong, J., Chen, R., Zhang, Z., Liu, D., Sun, J. M., & Chen, H. (2021) · Journal of Diabetes Research · doi:10.1155/2021/5551216 · Cited by 18
Jiang, J., Zhang, Q.-P., Ren, H., Yao, Q.-Y., Liu, G., & Lu, P. (2023) · International Journal of Ophthalmology · doi:10.18240/ijo.2024.01.04 · Cited by 17
Association between glycemia risk index and arterial stiffness in type 2 diabetes
Cai, L., Shen, W., Li, J., Wang, B., Sun, Y. B., Chen, Y., Gao, L., Xu, F., Xiao, X., Wang, N., et al. (2024) · Journal of Diabetes Investigation · doi:10.1111/jdi.14153 · Cited by 17
Glycemic Status Assessment by the Latest Glucose Monitoring Technologies
Malandrucco, I., Russo, B., Picconi, F., Menduni, M., & Frontoni, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218243 · Cited by 17
Hsing, S.-C., Lin, C. S., Chen, J., Chen, Y., & Fang, W. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11080799 · Cited by 17
Report from the CVOT Summit 2021: new cardiovascular, renal, and glycemic outcomes
Schnell, O., Battelino, T., Bergenstal, R. M., Blüher, M., Böhm, M., Brosius, F. C., Carr, R. D., Ceriello, A., Forst, T. M., Giorgino, F., et al. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01481-0 · Cited by 17
Cheung, Y.-M. M., Hughes, M. E., Harrod, J. C., Files, J. L., Kirkner, G., Buckley, L., Lin, N., Tolaney, S. M., McDonnell, M. E., & Min, L. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac375 · Cited by 17
CHANDRAN, S. R., Vigersky, R. A., Thomas, A., Lim, L., Ratnasingam, J., Tan, A. T. B., & Gardner, D. S.-L. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0277 · Cited by 17
Self-citationYing, L., Ma, X., Lu, J., Lu, W., Zhu, W., Vigersky, R. A., Jia, W., Bao, Y., & Zhou, J. (2019) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13099 · Cited by 16
Self-citationMiya, A., Nakamura, A., Handa, T., Nomoto, H., Kameda, H., Cho, K. Y., Nagai, S., Ito, Y. M., Miyoshi, H., & Atsumi, T. (2021) · Scientific Reports · doi:10.1038/s41598-021-88749-9 · Cited by 16
Zhou, H., Wang, W., Shen, Q., Feng, Z., Zhang, Z., Lei, H., Yang, X., Liu, J., Lü, B., Shao, J., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1014568 · Cited by 16
Yang, Y., Tan, J., He, Y., Huang, H., Wang, T., Gong, J., Liu, Y., Zhang, Q., & Xu, X. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1099302 · Cited by 16
Metadata
- Authors
- Lu, J., Ma, X., Zhou, J., Zhang, L., Mo, Y., Ying, L., Lu, W., Zhu, W., Bao, Y., Vigersky, R. A., & Jia, W.
- Affiliations
- Shanghai Jiao Tong University (CN)
- Walter Reed National Military Medical Center (US)
- Corresponding author
- Zhou, Jian
- Jia, Weiping
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2018-09-10
- Volume
- 41
- Issue
- 11
- Pages
- 2370-2376
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2891930016
- Cited by
- 517
- References
- 32
- Citations by year
- 2026: 45 · 2025: 55 · 2024: 61 · 2023: 70 · 2022: 87 · 2021: 85 · 2020: 71 · 2019: 40 · 2018: 1
- FWCI
- 39.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81100590)
- Shanghai Municipal Education Commission (20161430)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- time in range, continuous glucose monitoring, diabetic retinopathy, type 2 diabetes, glycemic variability, glycemic control, non-proliferative diabetic retinopathy, vision-threatening diabetic retinopathy, retinopathy severity
- MeSH terms
- Aged, Blood Glucose, Blood Pressure, Diabetes Mellitus, Type 2, Diabetic Retinopathy, Female, Fundus Oculi, Humans, Male, Middle Aged, Predictive Value of Tests, Prognosis, Reference Values, Retrospective Studies, Time Factors, Blood Glucose Self-Monitoring
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.